Penas-Prado, M, Yuan, Y, Wall, K, Vera, E, Ikiddeh-Barnes, U, Blackburn, K, Chambers, C, Ratnam, N, Frederico, S, Acquaye, A, Aldape, K, Briceno, N, Choi, A, Christ, A, Jammula, V, Leeper, H, Levine, J, Lindsley, M, Reyes, J, Roche, K, Rogers, J, Timmer, M, Boris, L, Burton, E, Lollo, N, Panzer, M, Polskin, L, Pillai, V, Quezado, M
, Theeler, B, Wu, J, Armstrong, T & Gilbert, M 2021, '
CTIM-32. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A HEAVILY PRETREATED COHORT',
Neuro-Oncology, vol. 23, no. Supplement_6, pp. vi57-vi58.
https://doi.org/10.1093/neuonc/noab196.224